Skip to main content
. 2022 Dec 8;12:1075685. doi: 10.3389/fonc.2022.1075685

Table 2.

Comparison of primary clinical data between patients with BCS duration time less than one year and BCS duration time more than one year.

n BCS duration time P
<1year (n=55) >1year (n=58)
Age 49.5 ± 14.5 48.9 ± 14.5 0.83
Gender 0.08
male 73 31 42
female 40 24 16
Hepatic venous outflow tract obstruction subtype 0.60
obstruction of IVC 50 27 23
hepatic vein occlusion 13 6 7
Mixed type 50 22 28
HBsAg 0.67
positive 5 3 2
negative 108 52 56
Laboratory examination
ALT <0.01
<40 U/L 87 34 53
>40 U/L 26 21 5
AST 0.02
<40 U/L 78 32 46
>40 U/L 35 23 12
Total bilirubin 0.82
<21 μM/L 44 22 22
>21 μM/L 69 33 36
albumin 0.31
>35 g/L 79 36 43
<35 g/L 34 19 15
PT-INR 0.99
<1.2 74 36 38
>1.2 39 19 20
PLT 0.79
>100*1012/L 59 28 31
<100*1012/L 54 27 27
WBC 0.79
>4*109/L 61 29 32
<4*109/L 52 26 26
Hb 0.76
>131 g/L 62 31 31
<131 g/L 51 24 27
Hepatic encephalopathy 0.74
+ 9 5 4
104 50 54
ascites <0.01
+ 49 33 17
64 23 41